Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Holsti

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Annals of Clinical Research|January 1, 1986
Prognostic factors in neuroblastomaM Kajanti, P Holsti
Acta Oncologica (Stockholm, Sweden)|January 1, 1987
Effects of roentgen irradiation on human melanoma metastases in the skinR Salmi, P Holsti
Acta Oncologica (Stockholm, Sweden)|January 1, 1989
Treatment of small cell lung cancer. Two-drug versus four-drug chemotherapy and loco-regional irradiation with or without prophylactic cranial irradiationA Niiranen, P Holsti, M Salmo
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 1, 1991
Radical surgery and postoperative split-course radiotherapy in squamous cell carcinoma of the mobile tongue: factors influencing local control and the time to recurrenceM Kajanti, L R Holsti, P Holsti
International Journal of Radiation Oncology, Biology, Physics|May 20, 1993
Effect of split-course radiotherapy on survival and local control in advanced localized prostatic carcinomaM Kajanti, L R Holsti, P Holsti, et al.
Thorax|May 1, 1983
Prognosis of cryptogenic fibrosing alveolitisP Tukiainen, E Taskinen, P Holsti, et al.
Cancer|June 15, 1985
Levamisole in the treatment of stage II breast cancer. Five-year follow-up of a randomized double-blind studyP Klefström, P Holsti, P Gröhn, et al.
Cancer|September 1, 1987
Adjuvant postoperative radiotherapy, chemotherapy, and immunotherapy in stage III breast cancer. II. 5-year results and influence of levamisoleP Klefström, P Gröhn, E Heinonen, et al.
American Journal of Clinical Oncology|December 1, 1987
Vincristine-cyclophosphamide, the classical two-drug regimen for small-cell lung cancer, evaluated in a randomized study with vindesineA Niiranen, L R Holsti, M Salmo, et al.
European Journal of Cancer & Clinical Oncology|July 1, 1989
A comparison of cis-platinum-vindesine and cis-platinum-etoposide combined with radiotherapy for previously untreated localized inoperable non-small cell lung cancerS Niitamo-Korhonen, P Holsti, L R Holsti, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Annals of Clinical Research|January 1, 1986
Prognostic factors in neuroblastomaM Kajanti, P Holsti
Acta Oncologica (Stockholm, Sweden)|January 1, 1987
Effects of roentgen irradiation on human melanoma metastases in the skinR Salmi, P Holsti
Acta Oncologica (Stockholm, Sweden)|January 1, 1989
Treatment of small cell lung cancer. Two-drug versus four-drug chemotherapy and loco-regional irradiation with or without prophylactic cranial irradiationA Niiranen, P Holsti, M Salmo
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 1, 1991
Radical surgery and postoperative split-course radiotherapy in squamous cell carcinoma of the mobile tongue: factors influencing local control and the time to recurrenceM Kajanti, L R Holsti, P Holsti
International Journal of Radiation Oncology, Biology, Physics|May 20, 1993
Effect of split-course radiotherapy on survival and local control in advanced localized prostatic carcinomaM Kajanti, L R Holsti, P Holsti, et al.
Thorax|May 1, 1983
Prognosis of cryptogenic fibrosing alveolitisP Tukiainen, E Taskinen, P Holsti, et al.
Cancer|June 15, 1985
Levamisole in the treatment of stage II breast cancer. Five-year follow-up of a randomized double-blind studyP Klefström, P Holsti, P Gröhn, et al.
Cancer|September 1, 1987
Adjuvant postoperative radiotherapy, chemotherapy, and immunotherapy in stage III breast cancer. II. 5-year results and influence of levamisoleP Klefström, P Gröhn, E Heinonen, et al.
American Journal of Clinical Oncology|December 1, 1987
Vincristine-cyclophosphamide, the classical two-drug regimen for small-cell lung cancer, evaluated in a randomized study with vindesineA Niiranen, L R Holsti, M Salmo, et al.
European Journal of Cancer & Clinical Oncology|July 1, 1989
A comparison of cis-platinum-vindesine and cis-platinum-etoposide combined with radiotherapy for previously untreated localized inoperable non-small cell lung cancerS Niitamo-Korhonen, P Holsti, L R Holsti, et al.
Pageof 2